Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Svetlana Lagoyko
Observed names:
S Lagoiko,
S N Lagoĭko,
S. Lagoyko,
S. N. Lagoiko,
S. N. Lagoyko,
Svetlana Lagoiko,
Лагойко С. Н.,
С Н Лагойко
show all 8
Institution:
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology
Observed institutions:
Ministry of Health of the Russian Federation,
Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology,
Regional Children's Clinical Hospital No. 1
ORCID:
0000-0002-3793-104X
Observed ORCID:
0000-0002-3793-104X
OpenAlex ID:
A5112646102
Absolute count of leukemic blasts in cerebrospinal fluid as detected by flow cytometry is a relevant prognostic factor in children with acute lymphoblastic leukemia
2019
·
Alexander Popov
, Guenter Henze
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
45
A simple algorithm with one flow cytometric MRD measurement identifies more than 40% of children with ALL who can be cured with low-intensity therapy. The ALL-MB 2008 trial results
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia
·
18
Reduced vs. standard dose native E. coli-asparaginase therapy in childhood acute lymphoblastic leukemia: long-term results of the randomized trial Moscow–Berlin 2002
2019
·
for the ALL-MB study group
, Alexander Karachunskiy
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
17
PDF
Blinatumomab as postremission therapy replaces consolidation and substantial parts of maintenance chemotherapy and results in stable MRD negativity in children with newly diagnosed B-lineage ALL
2024
·
Ekaterina Mikhailova
, Alexander Popov
, et al.
·
Journal for ImmunoTherapy of Cancer
·
16
One-point flow cytometric MRD measurement to identify children with excellent outcome after intermediate-risk BCP-ALL: results of the ALL-MB 2008 study
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Journal of Cancer Research and Clinical Oncology
·
14
A simple procedure to identify children with B‐lineage acute lymphoblastic leukemia who can be successfully treated with low or moderate intensity: Sequential versus single‐point minimal residual disease measurement
2023
·
Alexander Popov
, Guenter Henze
, et al.
·
Pediatric Blood & Cancer
·
12
Efficacy and toxicity of dexamethasone vs methylprednisolone—long-term results in more than 1000 patients from the Russian randomized multicentric trial ALL-MB 2002
2015
·
A Karachunskiy
, J Roumiantseva
, et al.
·
Leukemia
·
10
Strong expansion of normal CD19‐negative B‐cell precursors after the use of blinatumomab in the first‐line therapy of acute lymphoblastic leukaemia in children
2021
·
Ekaterina Mikhailova
, Julia Roumiantseva
, et al.
·
British Journal of Haematology
·
9
PDF
Flow cytometric MRD at the end of consolidation in childhood B-lineage acute lymphoblastic leukemia has significant prognostic value but limited clinical implications: Results of study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
8
Treatment of acute lymphoblastic leukemia in adolescents and young adults: the experience of the Moscow–Berlin
2016
·
A. V. Pshonkin
, Yu. V. Rumyantseva
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
·
7
PDF
A single flow cytometric MRD measurement in children with B-lineage acute lymphocytic leukemia and hyperleukocytosis redefines the requirements of high-risk treatment: Results of the study ALL-MB 2008
2022
·
Alexander Popov
, Guenter Henze
, et al.
·
Leukemia Research
·
6
Low-intensity therapy cures over 40 % of children with rapid Flow-MRD responding ALL: the ALL-MB 2008 trial results
2022
·
A. Popov
, G. Henze
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
6
PDF
Problems of flow cytometry immunophenotyping in Russia: Experience gained by the Reference Center of Moscow-Berlin Cooperative Clinical Group
2015
·
A. M. Popov
, S. N. Lagoiko
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
6
[Efficiency of the ALL-MB-2002 protocol in children with acute lymphoblastic leukemia].
2010
·
Iu V Rumiantseva
, A I Karachunskiĭ
, et al.
·
PubMed
·
6
Acute lymphoblastic leukemia in children with Down syndrome: comparative analysis of treatment results according to ALL-MB 2008 and ALL-MB 2015 protocols
2022
·
R. N. Suprun
, Yu. V. Rumyantseva
, et al.
·
Russian Journal of Pediatric Hematology and Oncology
·
5
PDF
Acute lymphoblastic leukemia in children with Down syndrome: “Moscow–Berlin” experience
2021
·
R. N. Suprun
, Yu. V. Roumiantseva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
5
PDF
Clinical significance of cytogenetic changes in childhood T-cell acute lymphoblastic leukemia: results of the multicenter group Moscow–Berlin (MB)
2018
·
Yulia Olshanskaya
, Anna Kazakova
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
5
Flow cytometric minimal residual disease monitoring in children with acute lymphoblastic leukemia treated by regimens with reduced intensity
2015
·
A. M. Popov
, Y. Yu. Verzhbitskaya
, et al.
·
Oncohematology
·
5
PDF
A hypodiploid karyotype in childhood B-cell precursor acute lymphoblastic leukemia
2021
·
Yu. V. Olshanskaya
, O. I. Soldatkina
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
4
PDF
Prognostic impact and clinical value of low levels of flow cytometric MRD at the end of induction in childhood B‐lineage acute lymphoblastic leukemia: Results of study ALL‐MB 2015
2025
·
Alexander Popov
, Guenter Henze
, et al.
·
HemaSphere
·
3
PDF
A Single Dose of PEG-Asparaginase at the Beginning of Induction Not Only Accelerates MRD Clearance but Also Improves Long-Term Outcome in Children with B-Lineage ALL
2023
·
Alexander Popov
, Günter Henze
, et al.
·
Cancers
·
3
PDF
Flow cytometric and cytomorphological definition of remission achievement in children with B-lineage acute lymphoblastic leukemia
2023
·
A. M. Popov
, G. A. Tsaur
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
PDF
The use of additional immunophenotypic criteria for the differential diagnosis of Burkitt lymphoma/leukemia: An exemplary case report
2021
·
Irina Demina
, Elena Zerkalenkova
, et al.
·
Leukemia Research
·
2
Intrachromosomal amplification of chromosome 21 (iAMP21) is the marker of unfavorable prognosis in childhood B-cell precursor acute lymphoblastic leukemia
2018
·
Yu. V. Olshanskaya
, A. N. Kazakova
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
Therapy of childhood T-cell acute lymphoblastic leukemia: Experience gained by the Russian-Byelorussian cooperative group
2015
·
G. R. Sharapova
, Yu. V. Rumyantseva
, et al.
·
Pediatric Hematology/Oncology and Immunopathology
·
2
Show more works
View as search
Works count:
44
Citation count:
226
H-index:
8
I10-index:
7
Year
Topic
Type